Assessing the Efficacy of Virtual Reality Analgesia (VRA) in Adult Patients for Pain Control During Spinal Injections (SI)

• Status: Withdrawn
• Trial end date: 2020-12-01
• Target enrollment: 0
• Participant gender: All

Summary

A three-group parallel randomized controlled trial to evaluate the efficacy of virtual reality analgesia (VRA) to decrease patient procedural pain and anxiety in the Adult patients undergoing Spinal Injections (SI).

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Albert Einstein College of Medicine; Albert Einstein College of Medicine, Inc.
• Treatments: Bupivacaine; Lidocaine

Criteria

Inclusion Criteria:

• Adult requiring Spinal Injections

• Adult > 18years

• Adults with intact vision who can attend VR intervention

Exclusion Criteria:

• Anyone < 18 years

• Adults who are not attentive to VR secondary to poor concentration, poor cognition to external stimuli

• Adults who request moderate IV sedation

• Adults with photic-induced seizures